Document Detail

Lower urinary tract symptoms (LUTS) and bladder afferent activity.
MedLine Citation:
PMID:  17654565     Owner:  NLM     Status:  MEDLINE    
AIMS: Dysregulation of bladder afferent activity and detrusor smooth muscle behavior leads to a constellation of lower urinary tract symptoms (LUTS), which includes overactive bladder (OAB). Current treatments for LUTS are poorly tolerated and may be associated with substantial adverse effects. METHODS: Major advances in the understanding of bladder neuroanatomy and the role of bladder afferent pathways in symptom generation suggest a range of targets for new therapeutic agents. RESULTS: A sensory role for urothelial and suburothelial structures has been established, as well as a cascade of afferent bladder signaling involving the bladder epithelium and detrusor muscle. Numerous inhibitory and stimulatory neurotransmitters and chemical mediators interact with a variety of specialized receptors and participate in signal transduction leading to wider neuroactivation. The blockade of muscarinic receptors, possibly mediated by muscarinic 2 (M(2)) receptors residing in the urothelium, has been shown to affect bladder afferent fibers, challenging the traditional concept that antimuscarinic therapy involves M(3) receptor-mediated effects on detrusor smooth muscle. The propagation of impulses to spinal and higher centers utilizes axonal fiber tracts remarkable for their morphologic and functional plasticity as bladder function becomes increasingly disordered. CONCLUSIONS: These findings suggest that the etiology of LUTS includes enhanced, dysregulated, and perhaps maladaptive sensory signaling arising from numerous pelvic locales, including the most superficial epithelium of the bladder.
Naoki Yoshimura
Related Documents :
16204795 - Poly(adp-ribose) polymerase-1 is a novel nuclear target for cholinergic receptor signal...
7624035 - Muscarine increases a voltage-independent potassium conductance through an m4 receptor ...
3927185 - Lack of interaction between thyrotropin releasing hormone and its analogs with 3h-quinu...
6627125 - Effects of age on muscarinic cholinergic receptors in rat myocardium.
2828985 - Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by eth...
12556415 - Mechanism by which brain-derived neurotrophic factor increases dopamine release from th...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neurourology and urodynamics     Volume:  26     ISSN:  0733-2467     ISO Abbreviation:  Neurourol. Urodyn.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-26     Completed Date:  2008-01-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8303326     Medline TA:  Neurourol Urodyn     Country:  United States    
Other Details:
Languages:  eng     Pagination:  908-13     Citation Subset:  IM    
Copyright Information:
(c) 2007 Wiley-Liss, Inc.
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Neurons, Afferent / physiology*
Receptor, Muscarinic M2 / physiology
Urinary Bladder / innervation*,  physiology*
Urinary Bladder, Overactive / physiopathology*
Urothelium / innervation,  physiology
Reg. No./Substance:
0/Receptor, Muscarinic M2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Imaging bladder sensations.
Next Document:  Urethral diverticula: a review and an update.